S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 89

Issue Date	Title / Author(s) / Citation	File
2002-11	A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer Chang, HM; Jung, KH; Kim, TY; Kim, WS; Yang, HK; Lee, KU; Choe, KJ; Heo, DS; Bang, YJ; Kim, NK Annals of Oncology, Vol.13 No.11, pp.1779-1785	DOI
2008-01	A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer Kim, Y. J.; Im, S. -A.; Kim, H. G.; Oh, S. Y.; Lee, K. W.; Choi, I. S.; Oh, D. Y.; Lee, S. H.; Kim, J. H.; Kim, D. W.; Kim, T. Y.; Kim, S. W.; Heo, D. S.; Yoon, Y. B.; Bang, Y. J. Annals of Oncology, Vol.19 No.1, pp.99-103	DOI
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2009-07	Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study Lee, Kyung Hee; Kim, Min Kyoung; Kim, Yeol Hong; Ryoo, Baek Yeol; Lim, Ho Yeong; Song, Hong Suk; Kim, Hoon Kyo; Lee, Myung Ah; Im, Seock Ah; Chang, Heung Moon; Cho, Jae Yong; Zang, Dae Young; Kim, Bong Seog; Kim, Jun Suk Cancer Chemotherapy and Pharmacology, Vol.64 No.2, pp.317-325	DOI
2009-10	Role of Adjuvant Chemoradiotherapy for Ampulla of Vater Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.75 No.2, pp.436-441	DOI
2010-02	A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer Oh, Do-Youn; Cha, Yongjun; Choi, In-Sil; Yoon, So-Young; Choi, In Keun; Kim, Jee Hyun; Oh, Sang Cheul; Kim, Chang Duck; Kim, Jae Sun; Bang, Yung-Jue; Kim, Yeul Hong Cancer Chemotherapy and Pharmacology, Vol.65 No.3, pp.527-536	DOI
2010-07	Is Duodenal Invasion a Relevant Prognosticator in Patients Undergoing Adjuvant Chemoradiotherapy for Distal Common Bile Duct Cancer? Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.77 No.4, pp.1186-1190	DOI
2011-03	Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: Correlation with fluorescence in situ hybridization Paik, Jin Ho; Choe, Gheeyoung; Kim, Hyojin; Choe, Ji-Young; Lee, Hyun Ju; Lee, Choon-Taek; Lee, Jong Seok; Jheon, Sanghoon; Chung, Jin-Haeng Journal of Thoracic Oncology, Vol.6 No.3, pp.466-472	DOI
2011-09	Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Soyeon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Kim, Woo-Ho; Kim, Young Tae; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.6 No.9, pp.1474-1480	DOI
2012-01	Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Bang, Yung-Jue; Kim, Young-Woo; Yang, Han-Kwang; Chung, Hyun Cheol; Park, Young-Kyu; Lee, Kyung Hee; Lee, Keun-Wook; Kim, Yong Ho; Noh, Sang-Ik; Cho, Jae Yong; Mok, Young Jae; Kim, Yeul Hong; Ji, Jiafu; Yeh, Ta-Sen; Button, Peter; Sirzen, Florin; Noh, Sung Hoon The Lancet, Vol.379 No.9813, pp.315-321	DOI
2012-06	A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research Oh, Do-Youn; Lee, Keun Wook; Lee, Kyung-Hee; Sohn, Chang-Hak; Park, Young Suk; Zang, Dae Young; Ryoo, Hun-Mo; Song, Hong-Suk; Kim, Jin-Soo; Kang, Hye-Jin; Kim, Bong-Seog; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.3, pp.1164-1174	DOI
2012-07	Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer Lim, Kyu-Hyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncology, Vol.83 No.2, pp.57-66	DOI
2012-07	Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer Lee, June Koo; Park, Heae Surng; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Cancer, Vol.118 No.14, pp.3579-3586	DOI
2012-07	MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome Lee, H. E.; Kim, M. A.; Lee, H. S.; Jung, E-J; Yang, H-K; Lee, B. L.; Bang, Y-J; Kim, W. H. British Journal of Cancer, Vol.107 No.2, pp.325-333	DOI
2012-08	Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation Lee, June Koo; Kim, Tae Min; Koh, Youngil; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon-Kyung; Chung, Doo Hyun; Yang, Seok-Chul; Kim, Young Tae; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.77 No.2, pp.460-463	DOI
2012-09	Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer Kim, Jae-Sung; Lim, Joo Han; Kim, Jee Hyun; Im, Seock-Ah; Chie, Eui Kyu; Hwang, Jin-Hyeok; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung Whan; Yoon, Yong Bum Cancer Chemotherapy and Pharmacology, Vol.70 No.3, pp.381-389	DOI
2012-11	Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - Differential treatment strategies for subtypes of early gastroesophageal cancer Lutz, Manfred P.; Zalcberg, John R.; Ducreux, Michel; Ajani, Jaffer A.; Allum, William; Aust, Daniela; Bang, Yung-Jue; Cascinu, Stefano; Hoelscher, Arnulf; Jankowski, Janusz; Jansen, Edwin P. M.; Kisslich, Ralf; Lordick, Florian; Mariette, Christophe; Moehler, Markus; Oyama, Tsuneo; Roth, Arnaud; Rueschoff, Josef; Ruhstaller, Thomas; Seruca, Raquel; Stahl, Michael; Sterzing, Florian; van Cutsem, Eric; van der Gaast, Ate; van Lanschot, Jan; Ychou, Marc; Otto, Florian European Journal of Cancer, Vol.48 No.16, pp.2941-2953	DOI
2013-01	Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases Kim, Hyojin; Xu, Xianhua; Yoo, Seol-Bong; Sun, Ping-Li; Jin, Yan; Paik, Jin Ho; Choe, Gheeyoung; Jheon, Sanghoon; Lee, Choon-Taek; Chung, Jin-Haeng Histopathology, Vol.62 No.2, pp.305-314	DOI
2013-05	Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy Lee, D-W; Han, S-W; Lee, H. J.; Rhee, Y-Y; Bae, J. M.; Cho, N-Y; Lee, K-H; Kim, T-Y; Oh, D-Y; Im, S-A; Bang, Y-J; Jeong, S-Y; Park, K. J.; Park, J-G; Kang, G. H.; Kim, T-Y British Journal of Cancer, Vol.108 No.10, pp.1978-1984	DOI
2013-07	Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib Park, Jin Hyun; Kim, Tae Min; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Clinical Lung Cancer, Vol.14 No.4, pp.383-389	DOI
2013-08	Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study Lee, J. K.; Shin, J. -Y.; Kim, S.; Lee, S.; Park, C.; Kim, J. -Y.; Koh, Y.; Keam, B.; Min, H. S.; Kim, T. M.; Jeon, Y. -K.; Kim, D. -W.; Chung, D. H.; Heo, D. S.; Lee, S. -H.; Kim, J. -I. Annals of Oncology, Vol.24 No.8, pp.2080-2087	DOI
2013-09	Adjuvant and Neoadjuvant Therapy for Gastric Cancer Oh, Do-Youn; Bang, Yung-Jue Current Treatment Options in Oncology, Vol.14 No.3, pp.311-320	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	DOI
2013-11	Nomogram Prediction of Survival and Recurrence in Patients With Extrahepatic Bile Duct Cancer Undergoing Curative Resection Followed by Adjuvant Chemoradiation Therapy Song, Changhoon; Kim, Kyubo; Chie, Eui Kyu; Kim, Jin Ho; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.87 No.3, pp.499-504	DOI
2013-11	Clinicopathologic Analysis of ROS1-Rearranged Non-Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm Go, Heounjeong; Kim, Dong-Wan; Kim, Donghyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue; Chung, Doo Hyun Journal of Thoracic Oncology, Vol.8 No.11, pp.1445-1450	DOI
2014-04	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non-Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor A Meta-analysis Lee, June-Koo; Hahn, Seokyung; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog JAMA - Journal of the American Medical Association, Vol.311 No.14, pp.1430-1437	DOI
2014-07	Quality of Life in the Trastuzumab for Gastric Cancer Trial Satoh, Taroh; Bang, Yung-Jue; Gotovkin, Evgeny A.; Hamamoto, Yasuo; Kang, Yoon-Koo; Moiseyenko, Vladimir M.; Ohtsu, Atsushi; Van Cutsem, Eric; Al-Sakaff, Nedal; Urspruch, Alexa; Hill, Julie; Weber, Harald A.; Chung, Hyun-Cheol Oncologist, Vol.19 No.7, pp.712-719	DOI
2014-08	Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600	DOI
2014-10	Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.4, pp.323-330	view file DOI
2014-11	Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer Ahn, H. S.; Jeong, S-H; Son, Y. G.; Lee, H-J; Im, S-A; Bang, Y-J; Kim, H-H; Yang, H-K British Journal of Surgery, Vol.101 No.12, pp.1560-1565	DOI
2014-11	Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non-Small-Cell Lung Cancer Blackhall, Fiona; Kim, Dong-Wan; Besse, Benjamin; Nokihara, Hiroshi; Han, Ji-Youn; Wilner, Keith D.; Reisman, Arlene; Iyer, Shrividya; Hirsh, Vera; Shaw, Alice T. Journal of Thoracic Oncology, Vol.9 No.11, pp.1625-1633	DOI
2014-11	Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial Noh, Sung Hoon; Park, Sook Ryun; Yang, Han-Kwang; Chung, Hyun Cheol; Chung, Ik-Joo; Kim, Sang-Woon; Kim, Hyung-Ho; Choi, Jin-Hyuk; Kim, Hoon-Kyo; Yu, Wansik; Lee, Jong Inn; Shin, Dong Bok; Ji, Jiafu; Chen, Jen-Shi; Lim, Yunni; Ha, Stella; Bang, Yung-Jue; the CLASSIC trial investigators The Lancet Oncology, Vol.15 No.12, pp.1389-1396	DOI
2014-12	Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial Jaenne, Pasi A.; Ou, Sai-Hong I.; Kim, Dong-Wan; Oxnard, Geoffrey R.; Martins, Renato; Kris, Mark G.; Dunphy, Frank; Nishio, Makoto; O'Connell, Joseph; Paweletz, Cloud; Taylor, Ian; Zhang, Hui; Goldberg, Zelanna; Mok, Tony The Lancet Oncology, Vol.15 No.13, pp.1433-1441	DOI
2014-12	First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer Solomon, Benjamin J.; Mok, Tony; Kim, Dong-Wan; Wu, Yi-Long; Nakagawa, Kazuhiko; Mekhail, Tarek; Felip, Enriqueta; Cappuzzo, Federico; Paolini, Jolanda; Usari, Tiziana; Iyer, Shrividya; Reisman, Arlene; Wilner, Keith D.; Tursi, Jennifer; Blackhall, Fiona; Boyer, M.; Ganju, V.; Hughes, B.; Pavlakis, N.; Solomon, B.; Varma, S.; Berghmans, T.; Canon, J-L; Demedts, I.; Janssens, A.; Louis, R.; Pieters, T.; Schallier, D.; Surmont, V.; da Silva, C. Maciel; Ferreira, C-G Moreira; Hirsh, V.; Joy, A.; Laberge, F.; Morzycki, W.; Wierzbicki, R.; Han, B.; Liu, X.; Qin, S.; Shi, Y.; Wang, Y.; Wu, G.; Wu, Y-L; Zhou, C.; Ahvonen, J.; Barlesi, F.; Cadranel, J.; Dansin, E.; Fayette, J.; Morere, J-F; Moro-Sibilot, D.; Pujol, J-L; Quoix, E.; Zalcman, G.; Frickhofen, N.; Schneider, C-P; Wehler, T.; Mok, T.; So, P.; Cuffe, S.; Bearz, A.; Boni, C.; Cappuzzo, F.; Cognetti, F.; De Braud, F.; De Pas, T.; Galetta, D.; Migliorino, M.; Rocco, D.; Scagliotti, G.; Tagliaferri, P.; Tiseo, M.; Aoe, K.; Hida, T.; Kato, T.; Kozuki, T.; Nakagawa, K.; Niho, S.; Nishio, M.; Nokihara, H.; Satouchi, M.; Seto, T.; Takahashi, T.; Ahn, J-S; Kim, D-W; Kim, S-W; Berchem, G.; Rodriguez, O. Arrieta; Biesma, B.; Dingemans, A-M; Smit, E.; Helland, A.; Barata, F.; Gorbunova, V.; Manikhas, G.; Orlov, S.; Leong, S.; Lim, H-L; Soo, R.; Tan, E-H; Nosworthy, A.; Villena, M. Codes; Felip, E.; Lopez, P. Garrido; Casado, D. Isla; Banaclocha, N. Martinez; Aix, S. Ponce; Aransay, N. Reguart; Abreu, D. Rodriguez; Perez, J. Trigo; Gautschi, O.; Pless, M.; Zippelius, A.; Chang, G-C; Tsai, Y-H; Shparyk, Y.; Blackhall, F.; Steele, N.; Armenio, V.; Dragnev, K.; Dugan, M.; Gadgeel, S.; Gerber, D.; Graziano, S.; Gurubhagavatula, S.; Horn, L.; Jalal, S.; Lauer, R.; Mehra, R.; Mekhail, T.; Mirshahidi, H.; Pakkala, S.; Polikoff, J.; Raftopoulos, H.; Saleh, M.; Salgia, R.; Waqar, S. New England Journal of Medicine, Vol.371 No.23, pp.2167-2177	DOI
2014-12	The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer Sim, Sung Hoon; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.12, pp.2135-2142	DOI
2015-01	TGF-β suppresses COX-2 expression by tristetraprolin-mediated RNA destabilization in A549 human lung cancer cells Kang, Soyeong; Min, Ahrum; Im, Seock-Ah; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Hyun-Ah; Kim, Hee-Jun; Oh, Do-Youn; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.1, pp.101-109	DOI
2015-07	Survival benefit of adjuvant chemoradiotherapy in patients with ampulla of vater cancer a systematic review and meta-analysis Kwon, Jeanny; Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Ha, Sung W. Annals of Surgery, Vol.262 No.1, pp.47-52	DOI
2015-08	Total lesion glycolysis in positron emission tomography can predict gefitinib outcomes in non-small-cell lung cancer with activating EGFR mutation Keam, Bhumsuk; Lee, Soo Jin; Kim, Tae Min; Paeng, Jin Chul; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon Kyung; Chung, Doo Hyun; Kang, Keon Wook; Chung, June-Key; Heo, Dae Seog Journal of Thoracic Oncology, Vol.10 No.8, pp.1189-1194	DOI
2015-10	Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations Park, Sehhoon; Keam, Bhumsuk; Kim, Se Hyun; Kim, Ki Hwan; Kim, Yu Jung; Kim, Jin-Soo; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Cancer Research and Treatment, Vol.47 No.4, pp.630-637	view file DOI
2015-11	Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure Cho, Kyoung Min; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.30 No.6, pp.891-898	view file DOI

1 2 3